Business Description
enVVeno Medical Corp
NAICS : 339113
SIC : 3841
ISIN : US29415J1060
Share Class Description:
STU:5HJ: Ordinary SharesDescription
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 32.61 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 | |||||
| 3-Year FCF Growth Rate | 36.8 | |||||
| 3-Year Book Growth Rate | 7.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.77 | |||||
| 9-Day RSI | 45.27 | |||||
| 14-Day RSI | 43.29 | |||||
| 6-1 Month Momentum % | 37.65 | |||||
| 12-1 Month Momentum % | 72.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 29.08 | |||||
| Quick Ratio | 29.08 | |||||
| Cash Ratio | 28.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.7 | |||||
| Shareholder Yield % | 0.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -62.68 | |||||
| ROA % | -58.12 | |||||
| ROIC % | -925.48 | |||||
| ROC (Joel Greenblatt) % | -1322.58 | |||||
| ROCE % | -65.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.54 | |||||
| Price-to-Tangible-Book | 1.59 | |||||
| EV-to-EBIT | -0.86 | |||||
| EV-to-EBITDA | -0.89 | |||||
| EV-to-FCF | -1.36 | |||||
| Price-to-Net-Current-Asset-Value | 1.65 | |||||
| Price-to-Net-Cash | 1.66 | |||||
| Earnings Yield (Greenblatt) % | -115.96 | |||||
| FCF Yield % | -27.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
enVVeno Medical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.535 | ||
| Beta | 2.01 | ||
| Volatility % | 106.43 | ||
| 14-Day RSI | 43.29 | ||
| 14-Day ATR (€) | 0.088417 | ||
| 20-Day SMA (€) | 4.437 | ||
| 12-1 Month Momentum % | 72.06 | ||
| 52-Week Range (€) | 2.36 - 6.05 | ||
| Shares Outstanding (Mil) | 13.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
enVVeno Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
enVVeno Medical Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
enVVeno Medical Corp Frequently Asked Questions
What is enVVeno Medical Corp(STU:5HJ)'s stock price today?
The current price of STU:5HJ is €4.36. The 52 week high of STU:5HJ is €6.05 and 52 week low is €2.36.
When is next earnings date of enVVeno Medical Corp(STU:5HJ)?
The next earnings date of enVVeno Medical Corp(STU:5HJ) is 2024-07-31 Est..
Does enVVeno Medical Corp(STU:5HJ) pay dividends? If so, how much?
enVVeno Medical Corp(STU:5HJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers